Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bronchial smooth muscle (often called airway smooth muscle or ASM) consists of specialized muscle cells in the walls of the bronchi and bronchioles responsible for regulating airway caliber. These cells contract to narrow the airway and relax to allow bronchodilation, thus playing a central role in airway resistance and bronchomotor tone[2][4]. In diseases such as asthma and COPD, airway smooth muscle exhibits altered contractile and proliferative responses, contributing to airflow obstruction and airway remodeling. The cell expresses a wide variety of molecular targets including G protein-coupled receptors (e.g., β2-adrenergic, muscarinic acetylcholine, histamine, endothelin receptors), ion channels, kinases (e.g., myosin light chain kinase), and structural proteins. Pharmacological agents for bronchoconstrictive diseases typically target these molecular entities to relax muscle tone or reduce muscle proliferation[3][4]. The term "bronchial smooth muscle targets" is thus not a valid canonical target, but an umbrella encompassing many different, more specific druggable molecular entities within smooth muscle.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bronchial smooth muscle targets.